The Efforts to Implement a Malaria Elimination Strategy in The Highly Endemic Malaria Region of Papua Province, Indonesia
Keywords:
Endemic, malaria, prevalence, risk factors, PapuaAbstract
In 2023, Indonesia’s Ministry of Health reported that nearly 75% of districts and cities in the country were free from malaria transmission, meaning 90% of the population lived in malaria-free zones. However, Papua Province, which accounts for only 1.5% of Indonesia’s population, continues to contribute over 90% of the national malaria cases, with more than 16,000 reported cases in 2023.Indonesia has recently completed a malaria vaccine trial, the IDSPZV1, which included the PfSPZ Vaccine and PfSPZ-CVac (CQ), conducted among soldiers deployed to Papua Province, New Guinea, for 10 months. These soldiers were from a battalion located in a malaria-free area in Bangkinang, Riau Province. The results of this clinical trial will be reported separately, but this significant development could offer a potential solution to reduce the risk of malaria infection, particularly among travelers, such as domestic tourists or soldiers visiting Papua.This edition highlights the recent findings from a malaria study conducted in Iwaka District, Mimika, Papua, which revealed that nearly half of the patients presenting with fever at the district hospital were diagnosed with malaria (N=863 patients). The authors explored various factors, including the prevalence of malaria, patient characteristics, history of malaria exposure, housing and environmental conditions, as well as malaria prevention measures among the study participants.In addition to uncomplicated malaria infections, severe malaria cases remain a significant issue, contributing to high mortality rates. Nainggolan et al. investigated the role of host factors, particularly ABO blood groups, in the likelihood of developing severe malaria.Understanding the dynamics of disease prevalence, and risk factors related to both the host and the environment, along with the potential availability of vaccines, chemoprevention, and other preventive measures, are crucial to achieving zero malaria in the island of New Guinea, Papua Province.References
Ministry of Health Republic of Indonesia. Malaria Report, 2024.
Monthly e-Sismal Report, 2023.
World Health Organization. Guidelines for Malaria. https://www.who.int/teams/global-malaria-programme/guidelines-for-malaria.
Indrihutami, K., Chand, K., Fahmia, R., et al. “Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population.” Am J Trop Med Hyg. 110(5), 2024, pp. 892–901.
[Au]. “Prevalence and Risk Factors of Malaria in Iwaka District, Mimika, Papua.”
Pekey A, Nainggolan L, Irawan C, et al. Association between ABO Blood Group and Malaria Severity in a Regional Referral Hospital in Jayapura, Papua, Indonesia. Acta Med Indones - Indones J Intern Med. 2024;56(4):476-82.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.